# Solco Healthcare US, LLC: Lisdexamfetamine Dimesylate Capsule shortage reverified (limited availability from this maker)

**Score:** 35/100

| Field | Value |
|---|---|
| Manufacturer | Solco Healthcare US, LLC |
| Drug | Lisdexamfetamine Dimesylate Capsule |
| Dosage form | Capsule |
| Therapeutic category | Psychiatry |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Limited availability |
| Reason | Shortage of an active ingredient |
| Presentations affected | 7 |
| Package NDCs | 43547-606-10, 43547-607-10, 43547-602-10, 43547-605-10, 43547-604-10, 43547-608-10, 43547-603-10 |
| Manufacturer supply note | On allocation |
| First posted | 2023-07-14 |
| Updated | 2026-06-29 |

## Why this score
- Limited availability.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.